We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Off-Label Marketing On Shaky Ground

Law360 (June 4, 2008, 12:00 AM EDT) -- The U.S. Department of Justice’s (“DOJ”) prosecution of pharmaceutical and medical device companies for alleged off-label marketing and the Food and Drug Administration’s (“FDA”) recent attempt to provide parameters for such marketing means that now, more than ever, pharmaceutical and medical device companies must be wary of the promotional materials they provide doctors.

Currently, the DOJ is investigating more than 150 drug and medical device manufacturers for alleged off-label promotions. The consequences for manufacturers accused of off-label marketing can be significant.

Last year, Pfizer Inc. paid...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.